Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Efficacy and Safety of Replase for Acute Ischemic Stroke: a Systematic Review and Meta-Analysis

Author:Maranhao Vieira Rodrigues, Natasha   De Sousa Marinho Mendes Filho, Frederico   Maia, Eva   Barbosa, Emanuelly Maria   Cauduro, Julia   Feitoza, Pablo   

Session Name:P7: Cerebrovascular Disease and Interventional Neurology: Revascularization for Acute Ischemia  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P7.020  

Author Institution:Universidade Federal do Amazonas (UFAM), Manaus, Brazil  

Ravulizumab in Patients with Generalized Myasthenia Gravis (gMG) from Japan: Real-world Outcomes

Author:Watanabe, Mitsuru   Sakurai, Kenzo   Uzawa, Akiyuki   Takahashi, Masanori   Suzuki, Shigeaki   Okuda, Masaki   Yungher, Benjamin   Yamamoto, Takanori   Utsugisawa, Kimiaki   Murai, Hiroyuki   

Session Name:P7: Neuromuscular and Clinical Neurophysiology (EMG): Neuromuscular Junction Disorders 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P7.023  

Author Institution:Kyushu University, Fukuoka, Japan  St. Marianna University School of Medicine, Kawasaki, Japan  Chiba University, Chiba, Japan  Osaka University Graduate School of Medicine, Osaka, Japan  Keio University School of Medicine, Tokyo, Japan  Alexion Pharma GK, Tokyo, Japan  Alexion, AstraZeneca Rare Disease, Boston, MA  Hanamaki General Hospital, Hanamaki City, Japan  International University of Health and Welfare, Narita, Japan  

Protocol to Help Neurologists Manage Subcutaneous Apomorphine Therapy Skin Nodules: Expert Roundtable Recommendations

Author:Isaacson, Stuart   Grall, Mindy   Gupta, Fiona   Kremens, Daniel   Nguyen, Cuong   Pahwa, Rajesh   Serota, Marc   Zirwas, Matthew   

Session Name:P7: Movement Disorders: Parkinson's Disease Management  

Topic:Movement Disorders  

Program Number:P7.023  

Author Institution:

Impact of Concomitant Therapy with a Dopamine Agonist on Converting Parkinson’s Disease Patients from Immediate-release Carbidopa-levodopa to CREXONT®

Author:Pahwa, Rajesh   Patel, Neepa   Falconer, Ramsey   Allard, Simon   Banisadr, Ghazal   Fisher, Stanley   

Session Name:P7: Movement Disorders: Parkinson's Disease Management  

Topic:Movement Disorders  

Program Number:P7.024  

Author Institution:University of Kansas Medical Center, Kansas City, KS  Rush University Medical Center, Chicago, IL  Inova Parkinson's & Movement Disorders Center, Alexandria, VA  Amneal Pharmaceuticals, Baltimore, MD  Amneal Pharmaceuticals, Evanston, IL  Amneal Pharmaceuticals, Warren, NJ  

Long-term Follow-up of Opicapone Use as Add-on to Levodopa in Parkinson’s Patients Without Motor Fluctuations: Findings from the EPSILON Study

Author:Ferreira, Joaquim   Rascol, Olivier   Stocchi, Fabrizio   Antonini, Angelo   Lapuente, Paloma   Castilla-Fernández, Guillermo   Brigas, Helena   Banisadr, Ghazal   Rocha, José-Francisco   Holenz, Joerg   Poewe, Werner   

Session Name:P7: Movement Disorders: Parkinson's Disease Management  

Topic:Movement Disorders  

Program Number:P7.027  

Author Institution:IMM Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa  CNS-Campus Neurológico, Instituto De Medicin, Portugal  Clinical Investigation Centre CIC1436 Departments of Neurosciences and Clinical Pharmacology, Centre of Excellence for Neurodegeneration COEN NeuroToul, and NS-Park/FCRIN network  University of Toulouse 3, University Hospital of Toulouse, INSERM, Toulouse, France  University San Raffaele Roma and Institute for Research and Medical Care IRCCS, Rome, Italy  BIAL – Portela & Ca S.A., CORONADO (S. Romão E S. Mamede, Portugal  Amneal Pharmaceuticals, Evanston, IL  Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria